Investor Relations
About Us | Investor Relations
More
Service Inquiry
Contact Eiromics to Learn More
Partnership
01Solutions
The Leader in Innovation and Breakthrough Technologies for Drug Delivery Systems!
Founded in 2025, Eiromics Biomedical focuses on developing innovative drug formulations. By leveraging advanced drug-delivery platform technologies, we are pioneering new therapeutic solutions for global healthcare. Through continuous innovation and breakthroughs, we are committed to providing patients with higher-quality treatment options.
Two Core Platforms, Pioneering the Future of Drug Delivery System!
Eiromics specialize in developing transdermal and ocular drug-delivery systems.
Through breakthrough formulation design, we optimize the therapeutic performance of existing drugs.
Our innovative delivery technologies not only reduce side effects but also significantly improve patient adherence and quality of life.
Through breakthrough formulation design, we optimize the therapeutic performance of existing drugs.
Our innovative delivery technologies not only reduce side effects but also significantly improve patient adherence and quality of life.
02Latest NEWS
Industry Highlights
Latest News, Breakthroughs & Media
NCHU College of Management Recommends Eiromics for Official Registration on GISA
National Chung Hsing University
2026.09.24
Alzheimer's Drug Reinvented: Eiromics Targets Market Opportunity with 7-Day Patch as Non-Invasive Drug Delivery Becomes New Battleground
SET News
2026.09.24
Eiromics to Register on GISA on September 23 (Stock Code: 7437)
Taipei Exchange (TPEx)
Date: 2026.09
![[TPEx Market] Eiromics to Register on GISA on September 23, Focusing on Dosage Form R&D to Optimize Therapeutic Efficacy](https://www.eiromics.com/archive/image/model/images/1790143402.jpg)
[TPEx Market] Eiromics to Register on GISA on September 23, Focusing on Dosage Form R&D to Optimize Therapeutic Efficacy
Commercial Times
2026.09.22
Eiromics to Register on GISA the Day After Tomorrow – Economic Daily News
Economic Daily News
2026.09.21
Inflammation of the eye leads to blindness? Rheumatic diseases could be the culprit
Health News Network
3 warning signs could indicate macular degeneration; Doctor warns: Initial symptoms are not obvious
NowNews
Date: 2026.06
A new steroid drug effectively improves macular edema and helps prevent vision loss.
Asia University Hospital
2020.03
The aging demographic: A burgeoning blue ocean for the pharmaceutical industry.
swissinfo.ch
2025.05
Eiromics Medical enters the Ophthalmology Market with ITRI Collaboration on Non-Invasive Eye Drops
Commercial Times
2025.09
President Lai Ching-te: Building a Trillion-Dollar Biotech Industry as Taiwan’s Next Guardian Mountain
Commercial Times, 2025.09
Photo Credit: Office of the President
Eiromics Medical Enters the Ophthalmology Market to Improve Care for Eye Disease Patients
Independence Evening Post
2025.09
Macular degeneration is the leading cause of blindness in people over 50
udn Vitality Network
2025.10
03CONTACT